Charlie Munger and his view of healthcare in the US.
Charlie, a friend, partner of Warren, has recently been vocal about his concerns about US healthcare, literally stating that it is a system that prolongs death to make more money and comparing patients to African carcasses. 🤔
I bought $39 worth of Pfizer $PFE stock and did a little research on their future intentions, where I clearly see growth potential + a regular and stable dividend. What about you?
Lately, it has been mostly technology stocks that have been up a few dozen percent. However, I am wondering what you currently see as potential buying opportunities.
I've been buying stocks recently, $MMM and $DIS. However, I am planning on buying shares of $CVS and $PFE.
Views on the current price and future of Pfizer $PFE?
The company is entering "the most important 18 months in Pfizer's history," CEO Bourla said in February. That's because the company plans to launch or expand the registration of 19 drugs over the next year and a half.
I guess it depends a lot if there's another pandemic coming or not... If so, I would definitely buy! :-D If not, this company is not interesting to me...
That's thanks to the results of a study showing the same, and potentially higher, efficacy of the new oral weight loss pills than competitor Novo Nordisk's popular Ozempic injection.
This is great news as it makes taking it easier and, for many, more affordable. However, the tablet will be further tested, but I think there is huge... Read more
I see that even if the covid ball is not solved so nice numbers cg to everyone who holds 💪 yesterday a lot of titles showed us that they are not written off yet
This company focuses and specializes in the development and research of immunotherapeutic drugs targeting the treatment of cancer and infectious diseases.
It is also known for the development and production of the COVID-19 vaccine with Pfizer.
Focus, specialization : production of drugs for humans and animals and the company also focuses on fighting various diseases such as : cancer, diabetes or Alzheimer's disease.
Products : Viagra or the vaccine against COVID-19.
After today's $PFE results, investors are likely to be tough on even competitor $CVS, which will report its results tomorrow before the market opens. So I expect a pullback, which I will use to increase my position. Anything around $70 is a nice price in my opinion. In fact, I don't think $CVS should come up with surprisingly good results.
I don't follow pharmaceutical companies much. Occasionally you can find nice ones that come up with a discovery (drug, method). Unfortunately, I've been burned by such startups. I don't know $CVS but I might look into a pharmaceutical company.
We use cookies to improve your experience on our site.
I'm going to $CVS